• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ranibizumab treatment for neovascular age-related macular degeneration in patients with good baseline visual acuity (better than 6/12): 12-month outcomes.

作者信息

Raja M S A, Saldana M, Goldsmith C, Burton B J L

出版信息

Br J Ophthalmol. 2010 Nov;94(11):1543-5. doi: 10.1136/bjo.2009.174763. Epub 2010 Jun 1.

DOI:10.1136/bjo.2009.174763
PMID:20516142
Abstract
摘要

相似文献

1
Ranibizumab treatment for neovascular age-related macular degeneration in patients with good baseline visual acuity (better than 6/12): 12-month outcomes.雷珠单抗治疗基线视力良好（优于6/12）的新生血管性年龄相关性黄斑变性患者：12个月的结果。
Br J Ophthalmol. 2010 Nov;94(11):1543-5. doi: 10.1136/bjo.2009.174763. Epub 2010 Jun 1.
2
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration.雷珠单抗治疗新生血管性年龄相关性黄斑变性的MARINA研究的亚组分析。
Ophthalmology. 2007 Feb;114(2):246-52. doi: 10.1016/j.ophtha.2006.10.045.
3
Ranibizumab treatment in patients with neovascular age-related macular degeneration and very low vision.雷珠单抗治疗新生血管性年龄相关性黄斑变性及严重低视力患者。
Acta Ophthalmol. 2011 Feb;89(1):e97. doi: 10.1111/j.1755-3768.2010.01899.x.
4
Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.在为期 2 年的 ANCHOR 研究中，雷珠单抗治疗以经典型为主的新生血管性年龄相关性黄斑变性的解剖获益。
Retina. 2010 Oct;30(9):1390-9. doi: 10.1097/IAE.0b013e3181e44599.
5
Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy.雷珠单抗治疗新生血管性年龄相关性黄斑变性的临床疗效观察。
Br J Ophthalmol. 2011 Apr;95(4):530-3. doi: 10.1136/bjo.2009.171868. Epub 2010 Oct 11.
6
A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.雷珠单抗治疗初治的年龄相关性黄斑变性继发非黄斑中心凹脉络膜新生血管的1年回顾性研究
Retina. 2009 Nov-Dec;29(10):1444-9. doi: 10.1097/IAE.0b013e3181ae712d.
7
Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration.雷珠单抗用于治疗年龄相关性黄斑变性继发的脉络膜新生血管。
Retina. 2007 Sep;27(7):846-50. doi: 10.1097/IAE.0b013e31813c68b7.
8
Ranibizumab for exudative age-related macular degeneration: 24-month outcomes from a single-centre institutional setting.雷珠单抗治疗渗出性年龄相关性黄斑变性：单中心机构设置的 24 个月结果。
Br J Ophthalmol. 2010 Mar;94(3):292-6. doi: 10.1136/bjo.2009.170670. Epub 2009 Dec 1.
9
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2.随机、双盲、假对照试验研究雷珠单抗治疗新生血管性年龄相关性黄斑变性：PIER 研究 2 年。
Am J Ophthalmol. 2010 Sep;150(3):315-324.e1. doi: 10.1016/j.ajo.2010.04.011. Epub 2010 Jul 3.
10
Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.雷珠单抗治疗临床环境中渗出性年龄相关性黄斑变性一年的结果。
Am J Ophthalmol. 2009 Sep;148(3):409-13. doi: 10.1016/j.ajo.2009.04.001. Epub 2009 May 24.

引用本文的文献

1
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression.临床实践中新生血管性年龄相关性黄斑变性的管理：系统评价、Meta分析和Meta回归
J Clin Med. 2022 Jan 10;11(2):325. doi: 10.3390/jcm11020325.
2
Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better.基线视力为20/60或更佳的眼睛中，玻璃体腔内药物治疗新生血管性年龄相关性黄斑变性的五年结果。
Clin Ophthalmol. 2019 Feb 13;13:347-351. doi: 10.2147/OPTH.S191170. eCollection 2019.
3
Factors predicting 2-year treatment results of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good baseline visual acuity.
预测基线视力良好的眼中雷珠单抗治疗息肉状脉络膜血管病变2年治疗结果的因素。
Medicine (Baltimore). 2018 Jun;97(25):e11188. doi: 10.1097/MD.0000000000011188.
4
Outcome of ranibizumab treatment in neovascular age related macula degeneration in eyes with baseline visual acuity better than 6/12.基线视力优于 6/12 的新生血管性年龄相关性黄斑变性眼应用雷珠单抗治疗的结果。
Eye (Lond). 2011 Dec;25(12):1617-21. doi: 10.1038/eye.2011.224. Epub 2011 Sep 16.
5
Effectiveness of ranibizumab intravitreal injections for exudative age-related macular degeneration treatment: 12-month outcomes.雷珠单抗玻璃体腔内注射治疗渗出性年龄相关性黄斑变性的疗效：12 个月的结果。
Med Sci Monit. 2011 Sep;17(9):CR485-90. doi: 10.12659/msm.881934.